Aerospace and defense company Ducommun (NYSE: DCO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 7.7% year on year to $209 million. Its non-GAAP profit of $0.75 per share was 4% above analysts’ consensus estimates.

Is now the time to buy DCO? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Ducommun's first quarter results surpassed Wall Street's expectations, driven by a robust rebound in commercial aerospace and continued strength in defense markets. Management attributed the quarter’s performance to higher production rates from original equipment manufacturers (OEMs), especially in single-aisle aircraft, and lower-than-anticipated inventory destocking. CEO Stephen Oswald noted, “Commercial aerospace, in particular, showed a major turnaround in the quarter with 18% year-over-year growth, a very positive sign.” Gross and adjusted EBITDA margins also expanded, reflecting the benefits of ongoing facility consolidation and strategic pricing initiatives.

Looking ahead, Ducommun’s management is focused on executing its Vision 2027 strategy, anticipating continued defense sector momentum and sustained commercial aerospace recovery. Oswald highlighted that growth in missile programs—driven by long-term agreements with key defense customers—will be a significant catalyst in the coming years. The company expects some lingering destocking impacts in the next few quarters, but believes these headwinds will subside by year-end, paving the way for additional growth. Management remains disciplined in pursuing acquisitions and emphasizes that capacity constraints should not limit the company’s ability to scale production as new orders materialize.

Key Insights from Management’s Remarks

Management credited the quarter’s performance to commercial aerospace growth, missile program strength, and disciplined execution of its long-term strategy, while noting ongoing destocking and evolving defense opportunities.

• Commercial aerospace rebound: The company cited a notable 18% year-over-year increase in commercial aerospace revenue, particularly from Airbus A220, A320, and Boeing 737 MAX programs. OEM production rate increases and less severe inventory destocking than anticipated drove this growth, with management expecting sustained momentum as Boeing ramps up output.

• Missile programs accelerate: Missile-related business continued its strong trajectory, growing 22% year-over-year in the quarter. Ducommun is positioned as a key supplier for multiple missile platforms, including Tomahawk and PAC-3, and expects multi-year growth as Department of War framework agreements with defense primes translate into higher production rates.

• Facility consolidation benefits: The company completed its facility consolidation projects at the end of last year, and cost-saving synergies are expected to total $13 million annually by the end of 2026. Management stated that these actions, combined with strategic pricing, contributed to margin improvement in Q1.

• Engineered product mix shift: Engineered products now represent 23% of Ducommun’s revenue—up from 15% in 2022—reflecting both organic growth and targeted acquisitions. Management emphasized that increasing this percentage remains the company’s top strategic priority.

• Acquisition discipline and board expansion: While actively seeking acquisitions to expand its engineered product portfolio, management stressed a disciplined approach to valuation. The recent appointment of the former Head of Northrop Mission Systems to the board is intended to bolster industry relationships and support strategic growth, especially in radar and electronic warfare segments.

Drivers of Future Performance

Ducommun’s outlook for the remainder of the year is shaped by continued defense tailwinds, a commercial aerospace recovery, and the timing of destocking normalization.

• Defense sector expansion: Management highlighted that missile program demand is expected to rise significantly over the next several years, supported by long-term agreements with defense primes and the Department of War. Production for platforms like Tomahawk and SM-6 is anticipated to ramp up, resulting in higher order activity as 2026 progresses and into 2027.

• Commercial aerospace normalization: While destocking may continue to affect growth in the next couple of quarters, management believes this headwind will diminish by year-end. As Boeing and Airbus increase build rates, Ducommun expects commercial aerospace volumes to rebound, benefiting from existing content on key platforms and new production lines coming online.

• Margin improvement focus: The company aims to achieve an adjusted EBITDA margin of 18% by 2027, up from 13% in 2022. This will be driven by further cost savings from facility consolidation, ongoing operational productivity enhancements, and a stronger mix of higher-margin engineered products. Management noted that capacity is sufficient to support projected growth, with the main challenge being timely recruitment and training for new production needs.

Catalysts in Upcoming Quarters

In the coming quarters, our team will be closely monitoring (1) the pace at which commercial aerospace destocking subsides and production rates increase at key OEMs; (2) the conversion of defense sector framework agreements into tangible orders and revenue, particularly for missile programs; and (3) the realization of cost synergies from facility consolidation. Successful execution in these areas will be crucial for achieving Ducommun’s growth and margin targets.

Ducommun currently trades at $144.95, up from $140.87 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.